The global Diphtheria, Pertussis, and Tetanus Vaccine market was valued at US$ 2522 million in 2023 and is anticipated to reach US$ 3296.6 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

Diphtheria, Pertussis, and Tetanus Vaccine Market

Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diphtheria, Pertussis, and Tetanus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria, Pertussis, and Tetanus Vaccine.

Report Scope

The Diphtheria, Pertussis, and Tetanus Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diphtheria, Pertussis, and Tetanus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diphtheria, Pertussis, and Tetanus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diphtheria, Pertussis, and Tetanus Vaccine Market Report

Report Metric	Details
Report Name	Diphtheria, Pertussis, and Tetanus Vaccine Market
Accounted market size in 2023	US$ 2522 million
Forecasted market size in 2030	US$ 3296.6 million
CAGR	3.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	DTaP Td Tdap
Segment by Application	Hospitals Clinics Vaccination Centers
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, GlaxoSmithKline, Sanofi, Lanzhou Institute of Biological, Merck, Novartis, AstraZeneca, Emergent, Astellas
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diphtheria, Pertussis, and Tetanus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Diphtheria, Pertussis, and Tetanus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Diphtheria, Pertussis, and Tetanus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Diphtheria, Pertussis, and Tetanus Vaccine Market growing?

Ans: The Diphtheria, Pertussis, and Tetanus Vaccine Market witnessing a CAGR of 3.9% during the forecast period 2024-2030.

What is the Diphtheria, Pertussis, and Tetanus Vaccine Market size in 2030?

Ans: The Diphtheria, Pertussis, and Tetanus Vaccine Market size in 2030 will be US$ 3296.6 million.

Who are the main players in the Diphtheria, Pertussis, and Tetanus Vaccine Market report?

Ans: The main players in the Diphtheria, Pertussis, and Tetanus Vaccine Market are Johnson & Johnson, GlaxoSmithKline, Sanofi, Lanzhou Institute of Biological, Merck, Novartis, AstraZeneca, Emergent, Astellas

What are the Application segmentation covered in the Diphtheria, Pertussis, and Tetanus Vaccine Market report?

Ans: The Applications covered in the Diphtheria, Pertussis, and Tetanus Vaccine Market report are Hospitals, Clinics, Vaccination Centers

What are the Type segmentation covered in the Diphtheria, Pertussis, and Tetanus Vaccine Market report?

Ans: The Types covered in the Diphtheria, Pertussis, and Tetanus Vaccine Market report are DTaP, Td, Tdap

1 Diphtheria, Pertussis, and Tetanus Vaccine Market Overview

1.1 Product Definition

1.2 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type

1.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Value Growth Rate Analysis by Type 2023 VS 2030

1.2.2 DTaP

1.2.3 Td

1.2.4 Tdap

1.3 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application

1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Value Growth Rate Analysis by Application: 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Vaccination Centers

1.4 Global Market Growth Prospects

1.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Estimates and Forecasts (2019-2030)

1.4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity Estimates and Forecasts (2019-2030)

1.4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Estimates and Forecasts (2019-2030)

1.4.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Average Price Estimates and Forecasts (2019-2030)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Manufacturers (2019-2024)

2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Manufacturers (2019-2024)

2.3 Global Key Players of Diphtheria, Pertussis, and Tetanus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Price by Manufacturers (2019-2024)

2.6 Global Key Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine, Product Offered and Application

2.8 Global Key Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine, Date of Enter into This Industry

2.9 Diphtheria, Pertussis, and Tetanus Vaccine Market Competitive Situation and Trends

2.9.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Concentration Rate

2.9.2 Global 5 and 10 Largest Diphtheria, Pertussis, and Tetanus Vaccine Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Diphtheria, Pertussis, and Tetanus Vaccine Production by Region

3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Region (2019-2030)

3.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Region (2019-2024)

3.2.2 Global Forecasted Production Value of Diphtheria, Pertussis, and Tetanus Vaccine by Region (2025-2030)

3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region (2019-2030)

3.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2019-2024)

3.4.2 Global Forecasted Production of Diphtheria, Pertussis, and Tetanus Vaccine by Region (2025-2030)

3.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Price Analysis by Region (2019-2024)

3.6 Global Diphtheria, Pertussis, and Tetanus Vaccine Production and Value, Year-over-Year Growth

3.6.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Production Value Estimates and Forecasts (2019-2030)

3.6.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Production Value Estimates and Forecasts (2019-2030)

3.6.3 China Diphtheria, Pertussis, and Tetanus Vaccine Production Value Estimates and Forecasts (2019-2030)

3.6.4 Japan Diphtheria, Pertussis, and Tetanus Vaccine Production Value Estimates and Forecasts (2019-2030)

4 Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region

4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2019-2030)

4.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2019-2024)

4.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Consumption by Region (2025-2030)

4.3 North America

4.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.3.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2019-2030)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.4.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2019-2030)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030

4.5.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2019-2030)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.6.2 Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2019-2030)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

5 Segment by Type

5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Type (2019-2030)

5.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Type (2019-2024)

5.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Type (2025-2030)

5.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Type (2019-2030)

5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Type (2019-2030)

5.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Type (2019-2024)

5.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Type (2025-2030)

5.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Type (2019-2030)

5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2019-2030)

6 Segment by Application

6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Application (2019-2030)

6.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Application (2019-2024)

6.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Application (2025-2030)

6.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Application (2019-2030)

6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Application (2019-2030)

6.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Application (2019-2024)

6.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Application (2025-2030)

6.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Application (2019-2030)

6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2019-2030)

7 Key Companies Profiled

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.1.2 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Main Business and Markets Served

7.1.5 Johnson & Johnson Recent Developments/Updates

7.2 GlaxoSmithKline

7.2.1 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.2.2 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.2.4 GlaxoSmithKline Main Business and Markets Served

7.2.5 GlaxoSmithKline Recent Developments/Updates

7.3 Sanofi

7.3.1 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.3.2 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.3.4 Sanofi Main Business and Markets Served

7.3.5 Sanofi Recent Developments/Updates

7.4 Lanzhou Institute of Biological

7.4.1 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.4.2 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.4.4 Lanzhou Institute of Biological Main Business and Markets Served

7.4.5 Lanzhou Institute of Biological Recent Developments/Updates

7.5 Merck

7.5.1 Merck Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.5.2 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.5.4 Merck Main Business and Markets Served

7.5.5 Merck Recent Developments/Updates

7.6 Novartis

7.6.1 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.6.2 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.6.4 Novartis Main Business and Markets Served

7.6.5 Novartis Recent Developments/Updates

7.7 AstraZeneca

7.7.1 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.7.2 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.7.4 AstraZeneca Main Business and Markets Served

7.7.5 AstraZeneca Recent Developments/Updates

7.8 Emergent

7.8.1 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.8.2 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.8.4 Emergent Main Business and Markets Served

7.7.5 Emergent Recent Developments/Updates

7.9 Astellas

7.9.1 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

7.9.2 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio

7.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production, Value, Price and Gross Margin (2019-2024)

7.9.4 Astellas Main Business and Markets Served

7.9.5 Astellas Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Chain Analysis

8.2 Diphtheria, Pertussis, and Tetanus Vaccine Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Diphtheria, Pertussis, and Tetanus Vaccine Production Mode & Process

8.4 Diphtheria, Pertussis, and Tetanus Vaccine Sales and Marketing

8.4.1 Diphtheria, Pertussis, and Tetanus Vaccine Sales Channels

8.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors

8.5 Diphtheria, Pertussis, and Tetanus Vaccine Customers

9 Diphtheria, Pertussis, and Tetanus Vaccine Market Dynamics

9.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Trends

9.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers

9.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges

9.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints

10 Research Finding and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

GlaxoSmithKline PLC

Sanofi

Lanzhou Institute of Biological

List of Tables

Table 1. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Value by Type, (US$ Million) & (2023 VS 2030)

Table 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Value by Application, (US$ Million) & (2023 VS 2030)

Table 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (Units) by Manufacturers in 2023

Table 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Manufacturers (2019-2024) & (Units)

Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Manufacturers (2019-2024)

Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Manufacturers (2019-2024) & (US$ Million)

Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Share by Manufacturers (2019-2024)

Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Industry Ranking 2022 VS 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2023)

Table 10. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price by Manufacturers (USD/Unit) & (2019-2024)

Table 11. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served

Table 12. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Types

Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) by Region (2019-2024)

Table 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Region (2019-2024)

Table 18. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) Forecast by Region (2025-2030)

Table 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share Forecast by Region (2025-2030)

Table 20. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Comparison by Region: 2019 VS 2023 VS 2030 (Units)

Table 21. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) by Region (2019-2024)

Table 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2019-2024)

Table 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) Forecast by Region (2025-2030)

Table 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share Forecast by Region (2025-2030)

Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Average Price (USD/Unit) by Region (2019-2024)

Table 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Average Price (USD/Unit) by Region (2025-2030)

Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Units)

Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2019-2024) & (Units)

Table 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Region (2019-2024)

Table 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Consumption by Region (2025-2030) & (Units)

Table 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Consumption Market Share by Region (2019-2024)

Table 32. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Units)

Table 33. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2019-2024) & (Units)

Table 34. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2025-2030) & (Units)

Table 35. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Units)

Table 36. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2019-2024) & (Units)

Table 37. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2025-2030) & (Units)

Table 38. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Units)

Table 39. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2019-2024) & (Units)

Table 40. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2025-2030) & (Units)

Table 41. Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Units)

Table 42. Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2019-2024) & (Units)

Table 43. Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2025-2030) & (Units)

Table 44. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) by Type (2019-2024)

Table 45. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) by Type (2025-2030)

Table 46. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Type (2019-2024)

Table 47. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Type (2025-2030)

Table 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) by Type (2019-2024)

Table 49. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) by Type (2025-2030)

Table 50. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Share by Type (2019-2024)

Table 51. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Share by Type (2025-2030)

Table 52. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Type (2019-2024)

Table 53. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Type (2025-2030)

Table 54. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) by Application (2019-2024)

Table 55. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) by Application (2025-2030)

Table 56. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Application (2019-2024)

Table 57. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Application (2025-2030)

Table 58. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) by Application (2019-2024)

Table 59. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) by Application (2025-2030)

Table 60. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Share by Application (2019-2024)

Table 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Share by Application (2025-2030)

Table 62. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Application (2019-2024)

Table 63. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Application (2025-2030)

Table 64. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 65. Johnson & Johnson Specification and Application

Table 66. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 67. Johnson & Johnson Main Business and Markets Served

Table 68. Johnson & Johnson Recent Developments/Updates

Table 69. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 70. GlaxoSmithKline Specification and Application

Table 71. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 72. GlaxoSmithKline Main Business and Markets Served

Table 73. GlaxoSmithKline Recent Developments/Updates

Table 74. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 75. Sanofi Specification and Application

Table 76. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 77. Sanofi Main Business and Markets Served

Table 78. Sanofi Recent Developments/Updates

Table 79. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 80. Lanzhou Institute of Biological Specification and Application

Table 81. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 82. Lanzhou Institute of Biological Main Business and Markets Served

Table 83. Lanzhou Institute of Biological Recent Developments/Updates

Table 84. Merck Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 85. Merck Specification and Application

Table 86. Merck Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 87. Merck Main Business and Markets Served

Table 88. Merck Recent Developments/Updates

Table 89. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 90. Novartis Specification and Application

Table 91. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 92. Novartis Main Business and Markets Served

Table 93. Novartis Recent Developments/Updates

Table 94. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 95. AstraZeneca Specification and Application

Table 96. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 97. AstraZeneca Main Business and Markets Served

Table 98. AstraZeneca Recent Developments/Updates

Table 99. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 100. Emergent Specification and Application

Table 101. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 102. Emergent Main Business and Markets Served

Table 103. Emergent Recent Developments/Updates

Table 104. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information

Table 105. Astellas Specification and Application

Table 106. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 107. Astellas Main Business and Markets Served

Table 108. Astellas Recent Developments/Updates

Table 109. Key Raw Materials Lists

Table 110. Raw Materials Key Suppliers Lists

Table 111. Diphtheria, Pertussis, and Tetanus Vaccine Distributors List

Table 112. Diphtheria, Pertussis, and Tetanus Vaccine Customers List

Table 113. Diphtheria, Pertussis, and Tetanus Vaccine Market Trends

Table 114. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers

Table 115. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges

Table 116. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Diphtheria, Pertussis, and Tetanus Vaccine

Figure 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Value by Type, (US$ Million) & (2023 VS 2030)

Figure 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Type: 2023 VS 2030

Figure 4. DTaP Product Picture

Figure 5. Td Product Picture

Figure 6. Tdap Product Picture

Figure 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Value by Application, (US$ Million) & (2023 VS 2030)

Figure 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application: 2023 VS 2030

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Vaccination Centers

Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) & (2019-2030)

Figure 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (Units) & (2019-2030)

Figure 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (Units) & (2019-2030)

Figure 16. Global Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Unit) & (2019-2030)

Figure 17. Diphtheria, Pertussis, and Tetanus Vaccine Report Years Considered

Figure 18. Diphtheria, Pertussis, and Tetanus Vaccine Production Share by Manufacturers in 2023

Figure 19. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. The Global 5 and 10 Largest Players: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2023

Figure 21. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Value Market Share by Region: 2019 VS 2023 VS 2030

Figure 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Comparison by Region: 2019 VS 2023 VS 2030 (Units)

Figure 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region: 2019 VS 2023 VS 2030

Figure 25. North America Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) Growth Rate (2019-2030)

Figure 26. Europe Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) Growth Rate (2019-2030)

Figure 27. China Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) Growth Rate (2019-2030)

Figure 28. Japan Diphtheria, Pertussis, and Tetanus Vaccine Production Value (US$ Million) Growth Rate (2019-2030)

Figure 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region: 2019 VS 2023 VS 2030 (Units)

Figure 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Region: 2019 VS 2023 VS 2030

Figure 31. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 32. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Country (2019-2030)

Figure 33. Canada Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 34. U.S. Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 35. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 36. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Country (2019-2030)

Figure 37. Germany Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 38. France Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 39. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 40. Italy Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 41. Russia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 42. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 43. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Regions (2019-2030)

Figure 44. China Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 45. Japan Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 46. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 47. China Taiwan Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 48. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 49. India Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 50. Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 51. Latin America, Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Country (2019-2030)

Figure 52. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 53. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 54. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 55. GCC Countries Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2019-2024) & (Units)

Figure 56. Global Production Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2019-2030)

Figure 57. Global Production Value Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2019-2030)

Figure 58. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Production Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2019-2030)

Figure 60. Global Production Value Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2019-2030)

Figure 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Application (2019-2030)

Figure 62. Diphtheria, Pertussis, and Tetanus Vaccine Value Chain

Figure 63. Diphtheria, Pertussis, and Tetanus Vaccine Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions